Strengths, Engagement: Catalysts for Growth at PTC Therapeutics -- S9E41




Gallup Called to Coach show

Summary: Join guests Martin Rexroad and Noam Farago of PTC Therapeutics as they share their company's emphasis on employee engagement and CliftonStrengths, and how that has helped it thrive during the pandemic. <br><br>View the complete transcript for this webcast, along with audio and video, at <a href="https://www.gallup.com/cliftonstrengths/en/354800/strengths-engagement-catalysts-for-growth-ptc-therapeutics.aspx" rel="noopener">https://www.gallup.com/cliftonstrengths/en/354800/strengths-engagement-catalysts-for-growth-ptc-therapeutics.aspx</a><br><br>Follow Us<br>Facebook -- <a href="https://www.facebook.com/CliftonStrengths/" rel="noopener">https://www.facebook.com/CliftonStrengths/</a> <br>LinkedIn -- <a href="https://www.linkedin.com/showcase/cliftonstrengths/" rel="noopener">https://www.linkedin.com/showcase/cliftonstrengths/</a><br>Instagram -- <a href="https://www.instagram.com/cliftonstrengths/" rel="noopener">https://www.instagram.com/cliftonstrengths/</a> <br>Twitter -- <a href="https://twitter.com/CliftonStrength" rel="noopener">https://twitter.com/CliftonStrength</a><br>Pinterest -- <a href="https://www.pinterest.com/CliftonStrengths/" rel="noopener">https://www.pinterest.com/CliftonStrengths/</a><br><br>Learn More About CliftonStrengths<br>Subscribe to the CliftonStrengths Newsletter -- <a href="https://bit.ly/30IjWMH" rel="noopener">https://bit.ly/30IjWMH</a> <br>How It Works -- <a href="https://bit.ly/36gD4mi" rel="noopener">https://bit.ly/36gD4mi</a> <br>34 CliftonStrengths Themes -- <a href="https://bit.ly/30FyexO" rel="noopener">https://bit.ly/30FyexO</a> <br>4 CliftonStrengths Domains -- <a href="https://bit.ly/36eLvyx" rel="noopener">https://bit.ly/36eLvyx</a> <br>The History -- <a href="https://bit.ly/30OggZZ" rel="noopener">https://bit.ly/30OggZZ</a> <br><br>Who’s It For<br>Individuals -- <a href="https://bit.ly/2ukUNf1" rel="noopener">https://bit.ly/2ukUNf1</a> <br>Teams -- <a href="https://bit.ly/3axoASj" rel="noopener">https://bit.ly/3axoASj</a> <br>Organizations -- <a href="https://bit.ly/38pj7Lm" rel="noopener">https://bit.ly/38pj7Lm</a> <br>Schools -- <a href="https://bit.ly/37gPvjl" rel="noopener">https://bit.ly/37gPvjl</a> <br><br>Popular Products<br>Assessments -- <a href="https://bit.ly/2Gi9Etf" rel="noopener">https://bit.ly/2Gi9Etf</a> <br>Materials and Tools -- <a href="https://bit.ly/3azKrZc" rel="noopener">https://bit.ly/3azKrZc</a> <br>Courses -- <a href="https://bit.ly/37ftuRP" rel="noopener">https://bit.ly/37ftuRP</a> <br>Books -- <a href="https://bit.ly/36jdfC2" rel="noopener">https://bit.ly/36jdfC2</a> <br><br>Additional Resources<br>Articles and Videos -- <a href="https://bit.ly/2TNAh19" rel="noopener">https://bit.ly/2TNAh19</a> <br>Webcasts -- <a href="https://bit.ly/2GeKHip" rel="noopener">https://bit.ly/2GeKHip</a> <br>Guides and Reports -- <a href="https://bit.ly/37erWI0" rel="noopener">https://bit.ly/37erWI0</a>